Broken String Biosciences

Broken String Biosciences is a leading biotechnology research company dedicated to turning breaks into breakthroughs in the realm of cell and gene therapy development. Through its innovative technology platform, INDUCE-seq™, Broken String Biosciences empowers companies to create safer and more effective therapies by design.

Broken String Biosciences' core offering, INDUCE-seq™, is a next-generation sequencing (NGS)-based DNA break mapping platform. This advanced technology enables precise measurement and quantification of off-target genetic edits, providing critical insights into associated genetic outcomes. By offering data-driven, actionable intelligence, Broken String Biosciences supports the advancement of gene editing programs across the discovery, pre-clinical, and clinical development stages.

Located at BioData Innovation Centre, Wellcome Genome Campus, Cambridge, CB10 1DR, GB, Broken String Biosciences is committed to pushing the boundaries of biotechnology. Broken String Biosciences continuously strives to enhance the potential of cell and gene therapies, ensuring safer and more predictable outcomes for patients. We invite the management team at Broken String Biosciences to create a customized and exclusive company showcase and product listing on our platform.